Clinical Trials Browser

Phase NA × spartalizumab × Gastrointestinal × Clear all

NCT06349044 2024-08-27

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03222440 2019-12-04

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Phase NA Unknown

Gastrointestinal

Advanced Gastric Adenocarcinoma

NCT03914352 2019-04-16

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT03671265 2019-01-09

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Phase NA Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03722875 2018-12-19

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular